title: Immune responses to inactivated vaccine in people naturally infected with hantaviruses.
abstract: An inactivated Hantaan virus vaccine for hemorrhagic fever with renal syndrome (HFRS) was given by injection to 15 people who were naturally infected with either Hantaan or Seoul viruses. Immunofluorescent antibody (IFA), reversed passive hemagglutination inhibition (RPHI), hemagglutination inhibition (HI), and neutralization antibody (NA) assays were used to measure the antibody titers of the vaccinated people before and after three doses of vaccine. The results indicated that IFA and RPHI antibody titers were boosted significantly (P < 0.05) after the vaccination. Either Hantaan or Seoul virus could induce two-way cross-reactive neutralization antibody responses in humans. After HTNV vaccine immunization, the NA titers of people with natural infection increased significantly (P < 0.05) to both Hantaan and Seoul viruses, while the relative dominance between these two type responses was still similar to that of natural infection. It is worthwhile to studying the procedure further to inoculate two different virus vaccines for improving the cross-protective effect.
authors.affiliation: Laboratory for HFRS, Zhejiang Health and Anti-epidemic Centre, People's Republic of China.
authors.forename: Q
authors.initials: Q
authors.lastname: Lu
authors.forename: Z
authors.initials: Z
authors.lastname: Zhu
authors.forename: J
authors.initials: J
authors.lastname: Weng
mesh_terms: D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D005455:Fluorescent Antibody Technique; D006476:Orthohantavirus / Q000276:immunology*; D006385:Hemagglutination Inhibition Tests; D006480:Hemorrhagic Fever with Renal Syndrome / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D009500:Neutralization Tests; D012189:Retrospective Studies; D015164:Vaccines, Inactivated / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D015164:Vaccines, Inactivated; D014765:Viral Vaccines